- BGN22.50m
- BGN27.14m
- BGN11.18m
Annual income statement for Etropal AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.73 | 7.67 | 11.7 | 6.75 | 11.2 |
| Cost of Revenue | |||||
| Gross Profit | 2.89 | 3.19 | 4.49 | 4.11 | 4.94 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.43 | 7.57 | 15.1 | 7.26 | 10.8 |
| Operating Profit | 0.292 | 0.105 | -3.41 | -0.511 | 0.333 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.008 | 0.025 | -3.46 | -0.783 | 0.032 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.009 | 0.026 | -3.41 | -0.81 | 0.032 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.009 | 0.024 | -3.44 | -0.718 | 0.127 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.009 | 0.024 | -3.44 | -0.718 | 0.127 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.005 | 0.02 | -0.246 | 0.059 | 0.306 |
| Dividends per Share |